Puig-Vives Montse, Osca-Gelis Gemma, Camprubí-Font Carla, Vilardell M Loreto, Izquierdo Angel, Marcos-Gragera Rafael
Unitat d'Epidemiologia i Registre de Càncer de Girona, Pla Director d'Oncologia, Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta (IDIBGI), Girona, España; Grup de Recerca en Estadística, Econometria i Salut (GRECS), Universitat de Girona, Girona, España; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública, España.
Unitat d'Epidemiologia i Registre de Càncer de Girona, Pla Director d'Oncologia, Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta (IDIBGI), Girona, España; Grup de Recerca en Estadística, Econometria i Salut (GRECS), Universitat de Girona, Girona, España; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública, España.
Med Clin (Barc). 2014 Oct 7;143(7):300-2. doi: 10.1016/j.medcli.2013.09.042. Epub 2013 Dec 28.
The aim of this study was to determine the tumor stage, the proportion of cases and the age specific rate of breast cancer (BC) cases according to detection method.
Cases of women aged 50 to 69 years diagnosed with BC in the Girona province during 1999-2006 were extracted from the population-based Girona Cancer Registry (n=1,254). BC was classified by detection method: screen-detected cancer, interval cancer and others. Proportion of cases and age-specific incidence were calculated according to detection method.
During the period 2002-2006, the proportion of screen-detected cancers, interval cancers and other cancers were 42.2%, 5.8% and 52.2%, respectively. After implementation of the early detection of breast cancer program (PDPCM), the incidence of screen-detected cases raised; thereafter, interval cancers also increased and the rate of other cancers decreased.
In the Girona province during the fully implemented PDPCM period (2002-2006), interval cancers represented a low proportion (5.8%) of women diagnosed with BC at 50 to 69 years old.
本研究旨在根据检测方法确定乳腺癌（BC）的肿瘤分期、病例比例以及特定年龄发病率。
从基于人群的赫罗纳癌症登记处提取了1999 - 2006年期间在赫罗纳省诊断为BC的50至69岁女性病例（n = 1254）。BC按检测方法分类：筛查发现的癌症、间期癌和其他类型。根据检测方法计算病例比例和特定年龄发病率。
在2002 - 2006年期间，筛查发现的癌症、间期癌和其他癌症的比例分别为42.2%、5.8%和52.2%。实施乳腺癌早期检测计划（PDPCM）后，筛查发现病例的发病率上升；此后，间期癌也增加，其他癌症的发病率下降。
在全面实施PDPCM的时期（2002 - 2006年），赫罗纳省50至69岁被诊断为BC的女性中间期癌所占比例较低（5.8%）。
